INTRODUCTION
Amphiphilic copolymers self-assembling into micelles or nanoparticles play a key role in modern drug formulation strategies as a result of their capacity to protect and deliver drugs to the target site, e.g. tumors, with suitable pharmacokinetics. 1, 2 Drug loaded self-assemblies provide many advantages compared to low-molecular-weight drugs as they can reduce drug toxicity towards healthy tissues and increase the drug stability and the efficacy of drugs by changing the pharmacokinetics to more favorable one. Among amphiphilic copolymers, aliphatic polyester-based copolymers, in particular PEG-b-PLA and PEG-b-PLGA diblock copolymers, have been widely studied due to their degradability and biocompatibility. 3, 4 After many years of extensive research and development, some have finally been introduced to the market like the PEG-PLA-based Genexol ®5 which paves the way for future products and confirms the potential of polyester-based drug delivery systems.
Among the synthetic polyesters, poly(-caprolactone) (PCL) is well-known for its biocompatibility, its slower hydrolytic degradation compared to PLA or PLGA, its ability to load drugs and its mechanical properties similar to classical polyolefins. These properties make it a valuable candidate for tissue engineering and medical devices. 6, 7 However, the use of PCL is not limited to macroscopic systems and many examples of micro-or nanosystems for drug delivery, i.e. micelles and particles, are described in literature. 8 All kinds of macromolecular architectures based on PCL and PEG have been proposed from classical diblock copolymers, to triblock copolymers, dendrimer-derived, star or miktoarm architectures. [9] [10] [11] [12] [13] The variety of macromolecular architectures and compositions has proved the potential of these polymer systems for cancer therapy and the impact of PCL-PEG copolymer amphiphilicity on the formation and shape of self-assemblies, 14, 15 drug loading, formulation stability 12, 16 and cellular internalization [17] [18] [19] have been studied. It was also demonstrated that PCL-PEG copolymers could act as modulators of drug efflux transporter P-glycoprotein in vitro, and therefore they could be of beneficial to the problematic treatment of multidrug resistance (MDR) cancer tumors. 20 In this context, graft copolymers are of particular interest, since their architecture allows an easy variation of the number of PEG chains along the polymer backbone and consequently of the resulting amphiphilicity. Graft copolymers also exhibit lower critical aggregation concentrations (CAC) compared to their linear analogs and they assemble into micelles with higher stability in serum and during freeze-drying process. 21, 22, 23, 24 As a consequence various polyester-g-PEG have been synthesized to date following either the "grafting through" or "grafting to" strategies. However, most of them are lactide-or glycolide-based polyesters, [25] [26] [27] [28] whereas only very little has been reported on PCL. For example, the group of Jerôme et al.
synthesized PCL-g-PEG via the "grafting to" process by reacting azido-CL and alkynyl endcapped PEG, by a CuAAC click chemistry approach. 29, 30 A similar approach was utilized by
Zhang et al. 31 or by Parrish et al. with an -propargyl--valerolactone. 32 A grafting through approach using a CL end-capped PEG that was copolymerized with CL was also proposed by
Rieger et al. 33 The main problem of these methods is the use of functional lactones whose synthesis is limited in terms of amount and whose polymerization can be problematic when high molecular weights are targeted. As a consequence, Coudane et al. proposed an alternative "grafting to" approach by using anionic post-polymerization modification of the carbonyl of a commercial PCL to graft chlorocarbonate PEG at the PCL -position. 34, 35 This one pot method is rapid and versatile, and the graft copolymer was easily prepared on a multigram scale. However, the grafting density influencing the self-assembly behavior is not well-controlled. To overcome this limitation we recently synthesized PCL-g-PEG, thanks to the combination of a scale-up friendly anionic post-polymerization modification of PCL and a subsequent grafting of PEG side chains via the fast and metal free photoradical thiol-yne reaction, which allowed an easy control of the copolymer amphiphilicity. The prepared PCLg-PEG polymers with EG/CL ratios ranging from 0.1 to 1.3 formed nanoparticles and frozen micelles of different hydrodynamic diameters. 36 Hydrophilicity of the previously prepared systems was however quite low, resulting in pegylated nanoparticles with low PEG density rather than micelle-like nanoaggregates, which may limit the release properties. In addition, the impact of the copolymer hydrophilic/hydrophobic balance on the ability to deliver various drugs was not investigated.
Here, a family of micelles-forming PCL-g-PEG with higher and controlled hydrophilicities (EG/CL ratios ranging from 2 to 5.5) is synthesized and characterized. 
Characterizations

NMR spectroscopy.
1 H NMR spectra were recorded at room temperature using an AMX300
Bruker spectrometer operating at 300 MHz. Deuterated chloroform and deuterated dimethyl sulfoxide were used as solvents, chemical shifts were expressed in ppm with respect to tetramethylsilane (TMS). Diffusion ordered spectroscopy (DOSY) experiments were performed on a Bruker Avance III spectrometer operating at 600 MHz, using deuterated dimethyl sulfoxide (DMSO) as solvent.
Size exclusion chromatography (SEC) was performed on a Viscoteck GPC-Max VE 2001 equipment fitted with a 2x30 cm long 5 µm mixed C PLgel columns and coupled with VE 3580 RI detector and VE 3210 UV/Vis detector. The mobile phase was THF at 1 mL/min flow rate at 30°C. Typically, polymer (10 mg) was dissolved in THF (2 mL) and the resulting solution was filtered through a 0.45 µm Millipore filter before injection of 20 µL of filtered solution. The number average molecular weight (M n ) and the dispersity (Ð) of the polymers were expressed according to calibration using polystyrene standards.
Fluorescence measurements and CAC determination. The CAC of the copolymers was determined by fluorescence spectroscopy using pyrene as a hydrophobic fluorescent probe.
Measurements were carried out on an RF 5302 Shimadzu spectrofluorometer (Japan) equipped with a Xenon light source (UXL-150S, Ushio, Japan). Briefly, an aliquot of pyrene solution (6×10 -6 M in acetone, 1 mL) was added to different vials, and the solvent was UV-spectrometry was performed on a Perkin-Elmer Precisely Lambda 35 spectrometer, with 1 cm optical path quartz cuvettes.
Synthesis of PCL-g-PEG
The PCL-yne/PEG-SH reactions were performed according to our previous work. 36 In typical experiment, PCL-yne (100 mg; 8% alkyne groups with respect to CL units, = 21300 g/mol ; Ð = 2.4); and PEG2k-SH (820 mg; 6 eq. with respect to the alkyne group) were dissolved in DMF (10 mL) in a Schlenk flask ( 
Preparation of nanoaggregates
Blank and drug loaded PCL-g-PEG nanoaggregates were prepared by the self-assembly method according to our previous article. 36 Typically, drug (5 mg) and PCL-g-PEG (35 mg) were dissolved in 2 mL acetone. Then 5 mL of PBS were added. The mixture was stirred one hour using an Ultra-Turrax stirrer (8000 rpm). The remaining acetone was evaporated under vacuum. The solution was then centrifuged for 10 min at 3600 rpm and 20°C before filtration through a 0.45 μm filter to eliminate the unloaded drug.
Determination of drug loading and encapsulation efficiency
Drug loading (DL) and encapsulation efficiency (EE) were determined by UV/Vis spectrophotometry at 425 nm for curcumin, 468 nm for clofazimine and 410 nm for elacridar.
Quantification of curcumin and clofazimine was performed with respect to a calibration curve The DL content and EE were calculated based on the following formulae:
with M D = mass of drug in nanoaggregates, M P = mass of copolymer and M Di = mass of drug initially added to prepare nanoaggregates.
Drug release kinetics
The release of curcumin from PCL-g-PEG nanoaggregates was assessed in phosphate buffer saline (PBS, pH 7.4) containing 0.1% w/v Tween 80 and 0.015% w/v ascorbic acid at 37 °C under constant orbital shaking (100 rpm ; Heidolph Unimax 1010). Tween is classically used to provide water-solubility to curcumin in such assays. [37] [38] [39] Ascorbic acid is a biomolecule naturally present in plasma, which is used to enhance the stability and avoid the degradation of the released curcumin. 40 In a typical release study, 2 mL of Curcumin/PCL-g-PEG micellar solution were poured in a dialysis bag (cut-off 3.5 kDa) that was immerged in 20 ml of buffer solution at 37°C. At specific time points, the entire release medium was removed and replaced with 20 mL fresh buffer solution. Collected samples were analyzed by UV-Vis spectrophotometry at 425 nm with reference to a calibration curve of curcumin in acetone:
water (20:80). The amount of released curcumin (Rc) was calculated based on the following formula:
with M RC = mass of released curcumin and M C = mass of curcumin in nanoaggregates.
Degradation of nanoaggregates
7 mg of copolymers PCL-g-PEG0.7k 1.2 and PCL-g-PEG2k 5.4 were dissolved in 1 ml of acetone in a hemolysis tube, and then 5 ml of PBS were added. After evaporation of acetone, hemolysis tubes were put in an incubator at 37°c under stirring at 150 rpm. Tubes were removed after 1 week, 1 month, 3 months and 6 months. Samples were freeze-dried, the solid residue was dissolved in THF and the resulting solution was filtered before analysis by SEC.
Degradation experiments were done in triplicates.
In vitro assay against MCF7 cells
Cell culture
Human breast cancer cell lines MCF-7 were a gift of Dr. Garcia's lab (IBMM, Team "Glyco et Nanovecteurs pour le ciblage thérapeutique", Montpellier, France). Cells were maintained in DMEM-F12 supplemented with Fetal Bovine Serum (10%, v/v) and 1%
penicillin/streptomycin at 37°C in a humidified incubator containing 5% CO 2 .
Cell cytotoxicity assay
Cytotoxicity of the nanoparticles was measured in MCF-7 cells using Prestoblue® Cell viability reagent (Invitrogen). For this assay, cells were plated into a 24-well plate in amount of 1.5×10 4 cells per well and allowed to attach overnight. They were then treated with 0.18 and 18 µg/ml of free curcumin (dissolved in DMSO) or curcumin encapsulated (dissolved in PBS) for 24h and 48h. Appropriate equivalent amounts of nanoparticles without curcumin were run simultaneously. Medium containing equivalent amounts of DMSO or PBS or medium only were used as a control. Cell viability was measured using Prestoblue® Cell viability reagent according to manufacturer's instruction. Briefly, 10% of Prestoblue® was diluted into cell growth medium. When added to cells, the reagent is modified by the reducing environment of the viable cells and turns red, becoming highly fluorescent. After incubation time, supernatant was transferred to a 96-well plate and the fluorescence was measured at 560/590nm using a microplate reader (PerkinElmer, Victor3V).
RESULTS AND DISCUSSION
Synthesis of graft copolymers with controlled amphiphilicity
A convenient thiol-yne photo-addition methodology was used to synthesize the PCL-g-PEG copolymers and to modulate their amphiphilicity. For sake of clarity, a schematic representation of the preparation and architecture of the PCL-g-PEG copolymers is provided (ESI, Scheme S1). Indeed, as shown in our previous work, it is possible to easily control the PEG grafting density by playing with the reaction parameters. 36 To evaluate the influence of PCL-g-PEG hydrophilicity on the copolymers potential as drug delivery systems, we targeted a broad range of hydrophilicity with molar ratios EG/CL in the range 1.9 to 5.4 (Table 1) . The increased number of composition and higher hydrophilicity of the novel PCL-g-PEG compared to our previously presented copolymers was obtained thanks to the precise control of the reactant concentration, the reaction time, the PEG-SH molecular weight, the number of PEG equivalents, and the amount of photoinitiator. The ratio EG/CL in product was easily increased from 1.9 to 2.8 by replacing PEG0.7K by PEG2K (entries 1 and 2), despite a lower number of PEG chains and DMPA equivalents. As expected and in accordance with our previous study with benzyl mercaptan, 36 higher grafting efficiency was obtained for the shorter PEG due to the limited steric hindrance and higher thiol-end group accessibility for PEG0.7K compared to PEG2K. The impact of the reactant concentration on the grafting density is significant as shown by the increase of EG/CL ratio from 2.8 to 4.5 for a 4 times lower solvent volume (entries 2 and 4). Moreover, reaction time played also significant role as EG/CL increased from 3.6 after 1 hour of reaction to 4.5 after 2 hours (entries 3 and 4).
Finally, the equivalent number of DMPA has only a limited impact on EG/CL ratio: EG/CL varies from 4.5 to 5 despite a 4 folds increase of DMPA equivalents was used (entries 3-5).
These results, in conjunction to the previously published, confirmed the simplicity of modulation offered by the photo thiol-yne approach to yield amphiphilic PCL-g-PEG copolymers that are easily turned from highly hydrophobic structures (EG/CL = 0.35, previous work) to more hydrophilic ones (EG/CL = 5).
Molecular weights, measured by SEC, were in the range 25000 g/mol to 30000 g/mol (Ð =1.6 to 2.7) and did not varied significantly for various copolymer. Further discussion of the molecular weights of the copolymers with respect to PCL-yne ( = 21200 g/mol Ð = 2.4) or comparison between the copolymers is not provided as hydrodynamic behavior of the copolymers is known to be strongly impacted by their amphiphilicity and architectures. In particular, underestimation of molecular weight of graft copolymers was reported in literature and is believed to be due to the impact of grafting density on hydrodynamic radius, which gives more compact structures than their linear counterparts.
26, 32
Characterization of PCL-g-PEG nanoaggregates
Critical aggregation concentrations (CAC) of PCL-g-PEGs
Critical aggregation concentrations (CAC) of PCL-g-PEGs were calculated for all copolymers using the excitation spectra of pyrene. Typical excitation spectra of pyrene solutions are shown in Figure S1 intensity ratio is related to the self-association of amphiphilic PCL-g-PEGs and the partition of pyrene between the aqueous phase and the hydrophobic cores of micelles. 41 CACs were estimated based on the tangents method and are listed in Table 2 . 
Size of PCL-g-PEGs nanoaggregates
All nanoaggregates have hydrodynamic diameters below 100 nm ( Table 2) 
Stability of self-assemblies
Degradation kinetics of the self-assemblies was evaluated under standard hydrolytic conditions over a 6 months period. For this purpose the two most different copolymers, namely PCL-g-PEG0.7k 1.2 and PCL-g-PEG2k 5.4 , were selected to generate blank nanoaggregates. At predetermined degradation times, buffer solutions of nanoaggregates (PBS, pH 7.4, 37°C) were analyzed by SEC (Figure 1 , ESI Table S1 ). Obviously, conditions
were not intending to recreate in vivo degradation conditions where such systems are expected to be degraded faster as a consequence of the lower pH found in tumor tissues (cancer tissues pH 6.5-7.2) or specific cell components (endosomes 5.0-6.5, lysosomes 4.5-5.0) 42 and of the presence of enzymes (lipases). 43 We aimed to do a comparative study to evaluate the impact of copolymer amphiphilicity and architecture on the in vitro degradation rate.
For both copolymers, release of PEG chains was witnessed. It results from the hydrolysis of the ester bond between the terminal hydroxyl-PEG group and the propionic acid used to prepare the PEG-SH. The first appearance of a peak corresponding to free PEG chains was seen after 1 month in the more hydrophobic PCL-g-PEG0.7k 1.2 ( Figure 1a ) and after only 1 week in the more hydrophilic PCL-g-PEG2k 5.4 ( Figure 1b) . By comparison of the relative intensities of peaks after 3 and 6 months, it may be concluded that all PEG side chains were hydrolyzed after 3 months in PCL-g-PEG0.7k 1.2 , whereas PEG release continued between 3 and 6 months in the more substituted PCL-g-PEG2k 5.4 . In summary, degradation starts earlier for the more hydrophilic copolymer, but due to a higher grafting number, it lasts over a longer period compared to the more hydrophobic copolymer. An additional comment should be done on the initial degradation period of the most hydrophobic copolymer. A high molecular weight population is formed after 1 week, still present after 1 month, to finally disappear after 3 months ( Figure 1a , shoulder peak at ca. 15 minutes). This is confirmed by DOSY-NMR analyses that also show the release of free PEG after 1 month (Figure 2 ). Different hypotheses can be done to explain this phenomenon. PCLg-PEG0.7k 1.2 is substituted in average by 13 PEG0.7K chains (Table 2) , whereas full substitution of the alkyne groups initially present on the PCL-yne would correspond to ca. 32 PEG0.7K chains. Some unreacted alkyne groups, and vinylsulfide groups (thiol-yne monoaddition) are therefore present in the copolymer. Rearrangements between these groups leading to cyclic compounds have been reported in litterature. 44 In a same manner, if considering the free alkyne groups and thioether groups, intramolecular chalcogenation has been reported following radical activation that may occur in our case due to the long exposition of degradation medium to day light. 45 Finally, another photoactivated side reaction is the direct crosslinking of vinylsulfide under light during the degradation. Taking into account these reactions, it is clear that some rearrangements leading to cross-linked structures may occur in the copolymer during its degradation and can explain the appearance of a population with higher molecular weight. For longer degradation times these cross-linked structures are also degraded and a clear decrease of molecular weight, as well as a lower dispersity, is again observed. A more detailed study on this aspect is however beyond the scope of the present work and is under way. However, one should note that all components of the PCL-g-PEG nanoaggregates will be excreted (released short PEG chains), and/or degraded (hydrolysis of PCL backbone), and thus unwanted accumulation of the carrier structure is not anticipated. Based on the presented results we can therefore conclude that the PCL-g-PEG copolymer nanoaggregates are suitable candidates as long circulating drug reservoirs for treatment of diseases, which need a long term exposure of the drug in the body. 
Encapsulation of drugs
Encapsulation of various API
To evaluate the potential of the PCL-g-PEG copolymer family for drug delivery, various APIs have been loaded into the nanoaggregates. The selected drugs were diverse in nature and therapeutic targets: anticancer drugs (paclitaxel, ABT-199), candidate drugs to overcome the multidrug resistance in cancer cells (curcumin, elacridar), anti-inflammatory drug (dexamethasone) and antibacterial drug (clofazimine). These drugs have usually a low to very low solubility, in the range 0.3 g/L for clofazimine to less than 0.4 mg/L for ABT-199 (Table   S2 , ESI), their body distribution after injection is non-selective, thus reaching also healthy cells and organ and finally, they show strong side-effect driven toxicity. Despite these drawbacks, they are very potent drugs with for example, activities below the nanomolar range for ABT-199. 46 It is therefore of interest to solubilize them, even at low dose, in drug delivery systems with the aim to highly increase their bioavailability, prolong their availability within the body while reducing significantly their side-effect toxicity. Changing of the pharmacokinetics is the key point to observe the better outcome of the treatment with selected drugs. For that purpose, two above described copolymers with different hydrophilicities (EG/CL = 1.2 or 3.2) and forming in the aqueous solution nanoaggregates have been chosen for preparation of loaded polymer-based drug nanoaggregates.
For all drugs, higher encapsulation efficiency and higher drug loading were obtained with the more hydrophobic copolymer, as expected ( Table 3 ). The EE was lowered by 22% (curcumin)
to 55% (ABT-199, Dexamethasone) by changing PCL-g-PEG0.7k 1.2 to PCL-g-PEG2k 3.2 .
Coming to more details, in the case of paclitaxel, the EE was considered too low (< 3 wt%) and DL was not calculated. Similarly, other polyester-based drug delivery systems have shown low efficiency in paclitaxel formulation when using self-assembly method and large quantities of polymer with respect to PTX (100:1) were therefore required. 47 On the opposite, very high EE (92 wt%) and DL (12.1 wt%) were obtained with curcumin. The same phenomenon was observed for clofazimine that was loaded at 11.7 wt% in the copolymer.
Finally, ABT-199 and Elacridar loadings were found very low (1.3 wt% and 2.6 wt%).
Nevertheless, these drugs are extremely potent and are still under deep pharmaceutical development and evaluation. We suppose that even quite low DLs might be enough to witness a therapeutic effect because of the highly improved pharmacokinetic profile and prolonged accessibility of the drug within the body. 
Encapsulation of curcumin
Based on the high EE and DL values obtained with curcumin, further experiments were carried out using this drug. Curcumin is a naturally occurring drug that exhibits potent antiinflammatory, anti-oxidant, anti-bacteria, anti-virus, anti-tumor and antilipidemic activities. 48, 49 However, it has a poor solubility and poor oral bioavailability. Therefore, a water-based formulation based on graft copolymers allowing a tunable and controlled release would be of interest. In order to evaluate if the modulation of curcumin loading and release can be achieved using PCL-g-PEG, copolymers with different amphiphilicities were tested. Lower
EEs and DLs with high hydrophilic copolymer were confirmed, EE decreasing from 92 wt% to 58 wt% and DL decreasing from 12.1 wt% to 8.2 wt% in PCL-g-PEG0.7k 1.2 and PCL-g-PEG2k 5.4 , respectively (Table 4 , entries 1 and 7). Roughly, three ranges of amphiphilicity can be drawn out of these results with similar EE and DL for each range: EE ≈ 90 wt% and DL ≈ 12 wt% for EG/CL ≤ 2 (entries 1-3); EE ≈ 70 wt% and DL ≈ 10 wt% for 2 ≤ EG/CL ≤ 3.5-4
(entries 4-5); and EE ≈ 55 wt% and DL ≈ 8-9 wt% for EG/CL ≥ 4.5 (entries 6-7). This shows the importance of the EG/CL ratio that impacts the resulting conformation of nanoaggregates.
As the amount of PEG is increased, higher amount of PEG chains are stuck into the structure of the nanoaggregates, resulting in a much less hydrophobic core, which does not represent a good environment to encapsulate hydrophobic drugs. Curcumin loaded samples were slightly larger than the blank nanoaggregates, except for the more hydrophilic copolymer PCL-g-PEG2k 5.4 whose average size decreased from 73 to 48 nm. It may be due to the fact that curcumin strongly interacts with PCL, 51 which may induce a more compacted structure of the initially looser and more swollen nanoaggregates obtained with the most hydrophilic copolymer. As for the blank nanoaggregates (Table 2) , and for the same reasons, the trend was that larger loaded nanoaggregates were obtained for the more hydrophilic copolymers. Polydispersity of drug loaded samples was large and not very different to the one of non-loaded samples showing that curcumin as low influence on the nanoaggregation behavior of the copolymers. This absence of influence is due to the less controlled self-aggregation of the graft copolymers and, for the lower EG/CL ratios, to the rapid folding of the hydrophobic core. One should note that for graft copolymers, a low extent of larger aggregates (< 30% in DLS intensity mode) is found with sizes between 100 and 200 nm depending on the copolymer. This was not observed with the well-defined linear PCL-b-PEG5k 2.6 giving of a more dynamic and homogenous system with better self-assembly compared to the uncontrolled self-aggregation of the graft copolymers. Noteworthy, PCL-g- 
Release of curcumin
Depending on the stability of the micelles, drugs can be released following the disruption/desintegration of the micelles and/or by diffusion. In the case of stable polymeric micelles, diffusion may be slow if favorable interactions exist between the drug and the core of micelles. To evaluate the impact of the copolymer composition on the drug release, curcumin-loaded PCL-g-PEG nanoaggregates with EG/CL = 1.9, 2.6 and 5.4 were prepared.
In vitro drug release was studied in PBS containing 0.1 wt% Tween 80 and 0.015 wt% ascorbic acid. Results are summarized in Figure 3 . No burst effect was observed and results showed similar kinetics profiles during the first 3 days with ca. 10% of the curcumin payload being released. Following this initial period, and as expected, the release was faster for nanoaggregates with higher hydrophilicity. 30% of curcumin payload was released in 20 days with PCL-g-PEG0.7k 1.9 , instead of 45% and 55% with PCL-g-PEG2k 2.6 and PCL-g-PEG2k 4.9 , respectively. Profiles were very similar for the two copolymers PCL-g-PEG2k 2.6 and PCL-gPEG2k 4.9 . This was confirmed by the curves fits that were calculated using the CurveExpert ≈ 55 nm). This is not the case for the block copolymers with the same EG/CL = 2.6 ratios but with lower molecular weight. A 21% release was reported after 24h for PEG2k-PCL2k diblocks, and ca. 50% release after 7 to 9 days. 38, 51 For comparison, similar ratios were obtained after 5 days and ca. 20 days with the graft copolymer PCL-g-PEG2k 2.6 .
Based on the results obtained during our study, we can conclude that our nanoaggregates are able to release their payload in a controlled manner, which is depending on the hydrophilicity of the used PCL-g-PEG. It is worth to mention that although the reported release kinetics may appear slow, the situation in the body is slightly different. First, as nanoaggregates are circulating in the body the released drug is immediately redistributed, thus the release kinetics will be the most probably significantly higher. Second, in the frame of cancer therapy such nanoaggregates are expected to rapidly accumulate in the tumor tissue due to the EPR effect,
where their payload will be more rapidly released that in vitro due to the faster in vivo degradation of copolyesters under the more acidic tumor environment. 
Toxicity of curcumin loaded nanoaggregates
Curcumin loaded PCL-g-PEG nanoaggregates were tested against breast cancer cell line MCF-7. All tests were performed with associated controls to check the non-toxicity of the various culture media used in cytotoxicity tests. In more details, the effect of a few percents of PBS in the culture medium has been assessed as the buffer is used to prepare the nanoaggregates suspensions prior to cell seeding. The same protocol was used with less than 0.1% of DMSO as cosolvent to ensure the solubility of the free curcumin in the culture medium in accordance with previous studies. 52 All media showed no toxicity ( Figure S3 , ESI). In a first assay, dose dependence viability of MCF-7 cells after 24h treatment was tested with the hydrophobic PCL-g-PEG0.7k 1.2 to confirm the non-toxicity of unloaded nanoagreggates, and to evaluate the toxicity of curcumin-loaded micelles with a range of curcumin concentration between 0.18 and 18 µg/mL. These concentrations were selected from the literature. (concentrations corresponds to µg/mL of curcumin in the culture medium and data are expressed as means ± SD and correspond to measurements in triplicate)
Based on these results, curcumin concentrations of 0.18 µg/mL (medium viability) and 18 µg/mL (low viability) were selected to evaluate the impact of the copolymer amphiphilicity on their cytotoxicity towards MCF-7 cells. Four copolymers with EG/CL ratios ranging from 1.9 to 5.4 were tested. The amount of loaded nanoaggregates added to the culture medium was adjusted based on the calculated drug loadings (Table 4) After 24h cell viabilities were in the range 30 to 40% for all formulations, including free curcumin. However, at the lower dose of 0.18 µg/mL the most hydrophobic copolymer PCLg-PEG0.7k 1.9 yielded the highest cytotoxicity. After 48h of treatment cells viability was only 60% for PCL-g-PEG0.7k 1.9 whereas all other formulations were not cytotoxic. These results show a higher cytotoxicity towards MCF-7 cancer cells for the most hydrophobic copolymer.
At low curcumin dose, a strong increase of activity is gained from the use of the PCL-g-PEG0.7k 1.9 copolymer compared to free curcumin. Considering the drug release profiles (Figure 3) , the observed differences cannot be ascribed to higher curcumin content in the culture medium as all copolymers would release the same amount of their payload after 48h
(~ 7%). The difference of activity is therefore based on differences in the PCL-g-PEG composition, architecture, and consequently on different amphiphilicity of the various nanoaggregates. Cellular uptake dependence over these factors is believed to be involved here. It was previously reported a higher cellular uptake for hydrophobic PEG2k-or PEG5k-PLA block and miktoarm copolymers with EG/LA > 2.5, 17 whereas some others reported the invert effect for PEG2k-PCL block copolymers with EG/CL < 2.5. 19 This discrepancy of interpretations demonstrates the difficulty to link the cytotoxic effect of drug loaded vectors with a single parameter. Beside pure release parameters, the resulting cytotoxicity depends on many factors that can influence the endocytosis pathways, such as particle size, morphology, surface charge, and of course the amphiphilicity of the copolymers.
Scheme 1.
Relative cytotoxicity of curcumin loaded nanoaggregates as a function of the EG/CL ratio, grafting number and PEG molecular weight.
In the present study, the higher efficiency of PCL-g-PEG0.7k 1.9 over its grafted counterparts is mainly related to the PEG chain length rather than the pure amphiphilic balance, the nanoaggregates sizes or the grafting number as supported by the following points. First, despite very different EG/CL ratios, all copolymers lead to loaded nanoaggregates of similar sizes (ca. 40 nm in diameter), which implies that size is not a critical factor. Second, considering the average grafting number, one should note that the grafting number of PCL-g- This is confirmed by the dissipative dynamics simulation study carried out by Zhang et al. 18 They investigate how nanoparticles coated with different amphiphilic copolymers penetrate the cells as a function of the entry force and penetration force needed to cross the cell membrane. Hydrophobicity, hydrophilic/hydrophobic blocks repartition but also rigidity of the polymer presented to the membrane had a strong impact. Rigid copolymers showed better capability and need less time to pass through the cell membrane. This is in total accordance with our findings where shorter, more rigid and less hydrophilic PEG0.7k segments are expected to require less energy to pass through the cell membrane compared to PEG2k ones.
An in depth study based on fluorescence microscopy will be undertaken in a future work to elucidate this particular point.
Finally, the importance of the architecture is clearly visible when comparing block and graft copolymers. Based on the PEG molecular weight and EG/CL ratio, one might expect a lower efficiency for the PCL-b-PEG5k 2.6 diblock copolymer but it is comparable to the PCL-g-PEG0.7k 1.9 graft copolymer. The polymer rigidity might again be a critical factor here.
In summary, the modulation offered by our synthetic approach for PCL-g-PEG copolymers
offers great opportunities and a high potential for efficient DDS with high cytotoxicity against selected MCF-7 cancer cell line.
Of course to prove the applicability of our nanoaggregates as DDS further investigation is needed and under way both in terms of formulation and freeze-drying of the DDS and in terms of in vivo applicability. However, considering the obtained results, it is our belief that the proposed PCL-PEG graft copolymers represent a good alternative to the classical diblock copolymers. Although the later might appear to date as more viable economically, PCL-PEG graft copolymers have various advantages compared to their linear counterparts. First, their CAC is about 10 times lower, which is of importance for formulation and economic reasons.
Second, although minor populations of larger aggregates are obtained with the graft copolymers, they present more compact structures with twice lower hydrodynamic diameters compared to their linear counterparts, which may be of benefit for tissue penetration. Last but not least, the proposed PCL-PEG graft copolymers present the main advantage of being tunable, depending on the target application. When diblock copolymers can only be functionalized on their chain ends, graft copolymers obtained by thiol-yne approach, thanks to the presence of unreacted alkyne groups (cf. grafting efficiency), could be further modified with higher substitution degrees or with multifunctionalities. This particular point should be the matter of future work.
CONCLUSION
In this work, the easy modulation offered by the photo thiol-yne approach to generate amphiphilic copolymers was shown. PCL-g-PEG copolymers whose amphiphilicity was easily tuned from hydrophobic (EG/CL = 1.9) to hydrophilic (EG/CL = 5.4) have been synthesized. Their CAC is low, in the range 1 to 5 mg/L, it increased with the increase of hydrophilicity. The grafting number was found to be critical for the CAC as PCL-g-PEG with the same grafting number present similar CAC values independently of the EG/CL ratio.
Nanoaggregates were easily loaded with various drugs with DL being dependent on the APIs.
Best results were obtained with curcumin that could be loaded at 12 wt%. The curcumin loaded nanoaggregates present sizes in the range 23 nm to 55 nm for all copolymers. All curcumin release curves present no burst effect although a faster release is obtained from the nanoaggregates with higher hydrophilicity. Finally, in terms of cytotoxicity against MCF-7 cells, PCL-g-PEG0.7k 1.9 is a better DDS candidate due to a combination of higher hydrophobicity and shorter PEG chains that may lead to a better cellular uptake in vitro. Of course the selection of suitable candidates for treatment of selected deseases has to be based on in vivo evaluation and we believe that the results summarized in the present paper could be usable for the selection of polymer nanoaggregates for future preliminary in vivo experiments.
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